<DOC>
	<DOCNO>NCT01854723</DOCNO>
	<brief_summary>This study compare safety , effectiveness , cost two different type long-acting insulin .</brief_summary>
	<brief_title>Comparison Study Insulin Glargine NPH Insulin</brief_title>
	<detailed_description>In study investigator compare two long-acting insulin , insulin glargine NPH insulin . The trial evaluate difference effectiveness , safety cost two agent use patient 80 unit 1unit/kg long-acting insulin . The investigator hypothesis patient switch lantus NPH improve blood glucose control .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>Adult patient 22 Providence Medical Group primary care clinic Diagnosis type 2 diabetes mellitus Currently use great 80 units/day insulin glargine great 1 unit/kg/day insulin glargine Current A1C &gt; 8.5 % ( within 3 month randomization ) Diagnosis type 1 diabetes mellitus Age &gt; 85 year Selfreported history severe hypoglycemia hypoglycemia unawareness Hospice/limited life expectancy Current enrollment Providence Medical Group Medication Assistance Program Current use GLP1 agonist ( i.e. , liraglutide , exenatide , exenatide extendedrelease ) End stage renal disease ( i.e. , dialysis estimate glomerular filtration rate &lt; 15 ml/min/1.73m2 ) Cirrhosis Unstable coronary artery disease chronic heart failure ( i.e . exacerbation hospitalization within 6 month prerandomization ) Psychiatric condition prevents adequate followup ( i.e. , &gt; 3 miss followup visit within 3 month period persistent nonadherence dose monitoring recommendation ) Active alcohol drug abuse Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Insulin glargine</keyword>
	<keyword>NPH insulin</keyword>
</DOC>